Breaking News Headlines Today | Ground News

Holiday Sale — Get 40% off Vantage for yourself or as a gift

HealthTech HotSpot image

News from HealthTech HotSpot

HealthTech HotSpot’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

HealthTech HotSpot’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about HealthTech HotSpot

Where is HealthTech HotSpot located?HealthTech HotSpot's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top HealthTech HotSpot News

L'Oreal to up stake in skin care firm Galderma to 20%

Switzerland · Switzerland

L'Oreal to up stake in skin care firm Galderma to 20%

57% Center coverage: 7 sources

L'Oreal said today it will raise its stake in Swiss skin care firm Galderma to 20% with an acquisition from a group of major shareholders, a step which could earn the French company a bigger cut of profits from the injectable cosmetics market.See the Story

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

Bothell · Bothell

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

75% Center coverage: 4 sources

BOTHELL, Wash.--(BUSINESS WIRE)--Dec 14, 2025-See the Story

Genesis Pharma Announces New Collaboration with Otsuka Pharmaceutical Europe Ltd.

Artificial Intelligence · Greece

Genesis Pharma Announces New Collaboration with Otsuka Pharmaceutical Europe Ltd.

GENESIS Pharma announces a new collaboration with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe.More...See the Story

Breaking News Topics Related to HealthTech HotSpot